Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

NDAQ:APHA - Post Discussion

Aphria Inc. > Aphria Rating change April 11 to April 17
View:
Post by DaveInCalgary on Apr 12, 2021 10:35pm

Aphria Rating change April 11 to April 17

Ratings change for Apr. 11, 2021 - Apr. 17, 2021
 
Date Symbol Brokerage Analyst Name 'Analyst Ranking out of 7,431' Rating  Current Target

12 Apr. 2021 CAAPHA Alliance Global Aaron Grey                    370    BUY       $24.00CA
12 Apr. 2021 USAPHA Alliance Global Aaron Grey                    370    BUY       $19.12US
 
12 Apr. 2021 CAAPHA CIBC     John Zamparo                        1,327   BUY        $28.00CA
12 Apr. 2021 USAPHA CIBC     John Zamparo                        1,327   BUY        $22.31US
 
11 Apr. 2021 CAAPHA BMO      Tamy Chen                             6,728   HOLD      $21.34CA
11 Apr. 2021 USAPHA BMO      Tamy Chen                             6,728   HOLD      $17.00US
Comment by skyplt on Apr 13, 2021 6:52am
Thanks Dave for this. Disappointed, but not surprised. Zamparo's 6 dollar haircut seems harsh. I believe 24CDN is realistic.
Aphria Inc.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities